Annual CFO
-$55.17 M
+$22.92 M+29.35%
31 December 2023
Summary:
Applied Therapeutics annual cash flow from operations is currently -$55.17 million, with the most recent change of +$22.92 million (+29.35%) on 31 December 2023. During the last 3 years, it has risen by +$23.04 million (+29.45%). APLT annual CFO is now -1626.85% below its all-time high of -$3.19 million, reached on 31 December 2017.APLT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$23.33 M
-$735.00 K-3.25%
30 September 2024
Summary:
Applied Therapeutics quarterly cash flow from operations is currently -$23.33 million, with the most recent change of -$735.00 thousand (-3.25%) on 30 September 2024. Over the past year, it has dropped by -$8.60 million (-58.43%). APLT quarterly CFO is now -1962.78% below its all-time high of -$1.13 million, reached on 31 March 2018.APLT Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$81.84 M
-$8.60 M-11.75%
30 September 2024
Summary:
Applied Therapeutics TTM cash flow from operations is currently -$81.84 million, with the most recent change of -$8.60 million (-11.75%) on 30 September 2024. Over the past year, it has dropped by -$27.78 million (-51.39%). APLT TTM CFO is now -7136.16% below its all-time high of -$1.13 million, reached on 31 March 2018.APLT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APLT Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +29.4% | -58.4% | -51.4% |
| 3 y3 years | +29.4% | -48.9% | +5.4% |
| 5 y5 years | -393.4% | -197.6% | -174.9% |
APLT Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +39.2% | -233.8% | +13.4% | -51.4% | +11.9% |
| 5 y | 5 years | -393.4% | +39.2% | -233.8% | +13.4% | -174.9% | +11.9% |
| alltime | all time | -1626.8% | +39.2% | -1962.8% | +13.4% | -7136.2% | +11.9% |
Applied Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$23.33 M(+3.3%) | -$81.84 M(+11.7%) |
| June 2024 | - | -$22.59 M(+19.5%) | -$73.24 M(+9.2%) |
| Mar 2024 | - | -$18.91 M(+11.2%) | -$67.09 M(+21.6%) |
| Dec 2023 | -$55.17 M(-29.3%) | -$17.00 M(+15.5%) | -$55.17 M(+2.1%) |
| Sept 2023 | - | -$14.73 M(-10.5%) | -$54.06 M(-7.9%) |
| June 2023 | - | -$16.45 M(+135.4%) | -$58.73 M(-3.2%) |
| Mar 2023 | - | -$6.99 M(-56.0%) | -$60.67 M(-22.3%) |
| Dec 2022 | -$78.09 M(-13.9%) | -$15.89 M(-18.0%) | -$78.09 M(-12.4%) |
| Sept 2022 | - | -$19.39 M(+5.4%) | -$89.14 M(+4.4%) |
| June 2022 | - | -$18.40 M(-24.6%) | -$85.42 M(-8.1%) |
| Mar 2022 | - | -$24.41 M(-9.4%) | -$92.92 M(+2.4%) |
| Dec 2021 | -$90.73 M | -$26.94 M(+72.0%) | -$90.73 M(+4.8%) |
| Sept 2021 | - | -$15.66 M(-39.5%) | -$86.54 M(-5.5%) |
| June 2021 | - | -$25.91 M(+16.6%) | -$91.56 M(+12.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$22.21 M(-2.4%) | -$81.57 M(+4.3%) |
| Dec 2020 | -$78.21 M(+115.4%) | -$22.75 M(+9.9%) | -$78.21 M(+15.2%) |
| Sept 2020 | - | -$20.69 M(+30.1%) | -$67.87 M(+23.4%) |
| June 2020 | - | -$15.91 M(-15.6%) | -$55.01 M(+14.2%) |
| Mar 2020 | - | -$18.86 M(+52.0%) | -$48.16 M(+32.6%) |
| Dec 2019 | -$36.31 M(+224.7%) | -$12.41 M(+58.3%) | -$36.31 M(+22.0%) |
| Sept 2019 | - | -$7.84 M(-13.5%) | -$29.77 M(+24.3%) |
| June 2019 | - | -$9.06 M(+29.4%) | -$23.95 M(+40.4%) |
| Mar 2019 | - | -$7.00 M(+19.3%) | -$17.05 M(+52.5%) |
| Dec 2018 | -$11.18 M(+250.0%) | -$5.87 M(+190.5%) | -$11.18 M(+110.5%) |
| Sept 2018 | - | -$2.02 M(-6.6%) | -$5.31 M(+61.3%) |
| June 2018 | - | -$2.16 M(+91.2%) | -$3.29 M(+191.2%) |
| Mar 2018 | - | -$1.13 M | -$1.13 M |
| Dec 2017 | -$3.19 M | - | - |
FAQ
- What is Applied Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Applied Therapeutics?
- What is Applied Therapeutics annual CFO year-on-year change?
- What is Applied Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Applied Therapeutics?
- What is Applied Therapeutics quarterly CFO year-on-year change?
- What is Applied Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Applied Therapeutics?
- What is Applied Therapeutics TTM CFO year-on-year change?
What is Applied Therapeutics annual cash flow from operations?
The current annual CFO of APLT is -$55.17 M
What is the all time high annual CFO for Applied Therapeutics?
Applied Therapeutics all-time high annual cash flow from operations is -$3.19 M
What is Applied Therapeutics annual CFO year-on-year change?
Over the past year, APLT annual cash flow from operations has changed by +$22.92 M (+29.35%)
What is Applied Therapeutics quarterly cash flow from operations?
The current quarterly CFO of APLT is -$23.33 M
What is the all time high quarterly CFO for Applied Therapeutics?
Applied Therapeutics all-time high quarterly cash flow from operations is -$1.13 M
What is Applied Therapeutics quarterly CFO year-on-year change?
Over the past year, APLT quarterly cash flow from operations has changed by -$8.60 M (-58.43%)
What is Applied Therapeutics TTM cash flow from operations?
The current TTM CFO of APLT is -$81.84 M
What is the all time high TTM CFO for Applied Therapeutics?
Applied Therapeutics all-time high TTM cash flow from operations is -$1.13 M
What is Applied Therapeutics TTM CFO year-on-year change?
Over the past year, APLT TTM cash flow from operations has changed by -$27.78 M (-51.39%)